Hengxu Mao

757 citations
22 papers · 499 indexed · h-index 12
Topics
Parkinson's Disease Mechanisms and Treatments (10 papers)MicroRNA in disease regulation (4 papers)Cancer-related molecular mechanisms research (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Hengxu Mao

21 papers receiving 491 citations

Peers

Hengxu Mao
Comparison fields: 5 of 65
  • Molecular Biology 304
  • Cancer Research 205
  • Neurology 100
  • Neurology 88
  • Cellular and Molecular Neuroscience 82
Replace Zongbo Zhao with:
Zongbo Zhao China
Honglin Yan China
Shiwei Wang China
Huimin Kong China
Xiaochen Bai China
Francesca Goffi Italy
Shengjun An China
Meng‐Xian Pan China
Xialin Zuo China
Jun‐Chun Tang China
Hengxu Mao relative to Zongbo Zhao China Zongbo Zhao's profile →
Citations per field
00.5×1.5×2.4×
Zongbo Zhao · 1×
Citations per year

Countries citing papers authored by Hengxu Mao

Since Specialization
Citations

This map shows the geographic impact of Hengxu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengxu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengxu Mao more than expected).

Fields of papers citing papers by Hengxu Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengxu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengxu Mao. The network helps show where Hengxu Mao may publish in the future.

Co-authorship network of co-authors of Hengxu Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Hengxu Mao. A scholar is included among the top collaborators of Hengxu Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengxu Mao. Hengxu Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 13
4 7
5 0
6 16
7 4
8 3
9 28
10 58
11 12
12 15
13 76
14 78
15 13
16 121
17 3
18 4
19
[Experimental studies of icariin on anticancer mechanism].
10
20
[Influence of icariin on cell membrane of highly metastatic human lung tumor cell line].
1

About Hengxu Mao

Hengxu Mao is a scholar working on Neurology, Cancer Research and Neurology, having authored 22 papers that have together received 499 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (10 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (205 citations), Neurology (100 citations) and Neurology (88 citations). Hengxu Mao has collaborated with scholars based in China and United States. Frequent co-authors include Shizhong Zhang, Yongyi Ye, Longping Yao, Xiaozheng He, Fengfei Lu, Guohui Lu, Baoyan Wang, Xiang Sun, Chen Qian and Yizhou Zhang. Their work appears in journals such as The FASEB Journal, Small and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026